ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases.

Sarah Jenkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.